Skip to main content
LWAY
NASDAQ Manufacturing

Lifeway Foods Reports Strong Q1 2026 Results with 36.7% Sales Growth and Major Capacity Expansion

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Food & Beverage Stocks · Consumer
Sentiment info
Positive
Importance info
8
Price
$28.11
Mkt Cap
$412.827M
52W Low
$17.31
52W High
$34.2
52W Position info
62% above low
Off High info
18% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

LWAY sits 62% above its 52-week low of $17.31.

Summary

Lifeway Foods announced strong Q1 2026 financial results, with net sales up 36.7% and net income increasing by 32%, alongside a major investment in manufacturing capacity expansion.


Key Events · Earnings and Guidance · LWAY

  • Strong Q1 2026 Financial Performance

    Net sales increased by 36.7% to $63.01 million, exceeding the preliminary guidance of 32-35% growth. Net income rose by 32.0% to $4.67 million, and basic EPS grew by 34.8% to $0.31 per share.

  • Improved Profitability

    Gross profit margin expanded to 27.5% in Q1 2026 from 24.0% in Q1 2025, driven by favorable milk pricing and manufacturing efficiencies from increased production volumes.

  • Significant Capital Expenditure for Expansion

    The company used $11.04 million in investing activities, primarily for the expansion and modernization of its Waukesha, Wisconsin facility. This project, with cumulative cash paid of $31.27 million as of March 31, 2026, is expected to double manufacturing capacity and improve efficiency, with completion anticipated in Q4 2026.

  • Increased Borrowings to Fund Growth

    Lifeway Foods borrowed $8.0 million under its revolving credit facility to help fund the facility expansion, with $7.0 million outstanding and $18.0 million remaining available as of March 31, 2026. The company remains in compliance with all debt covenants.


Analysis · LWAY · Manufacturing

Lifeway Foods reported robust first-quarter results, exceeding preliminary sales guidance and demonstrating significant operational improvements. The company's net sales surged by 36.7%, driven by increased kefir volumes, and gross profit margins expanded. A substantial investment in manufacturing capacity expansion, partially funded by a revolving credit facility, signals strong confidence in future demand and growth prospects. This filing confirms the positive preliminary sales announced earlier and provides full financial details, reinforcing a positive outlook for the company.

At the time of this filing, LWAY was trading at $28.11 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $412.8M. The 52-week trading range was $17.31 to $34.20. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LWAY - Latest Insights

LWAY
Jul 23, 2026, 4:47 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $30.33
Real-time Price: $31.06 info
Change: +$0.730 (+2%) info
Market Cap: $474.655M info
LWAY
Jul 07, 2026, 7:34 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $29.32
Real-time Price: $31.06 info
Change: +$1.74 (+6%) info
Market Cap: $474.655M info
LWAY
Jul 07, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $29.32
Real-time Price: $31.06 info
Change: +$1.74 (+6%) info
Market Cap: $474.655M info
LWAY
Jul 06, 2026, 5:17 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $29.64
Real-time Price: $31.06 info
Change: +$1.42 (+5%) info
Market Cap: $474.655M info
LWAY
Jul 02, 2026, 8:36 PM EDT
Filing Type: 4/A
Importance Score:
7
Price at Filing: $30.94
Real-time Price: $31.06 info
Change: +$0.120 (+0.39%) info
Market Cap: $474.655M info